← Eichor
Study identifier: NCT04240366 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation

Condition: Persistent or Long-standing Persistent Atrial Fibrillation  ·  Sponsor: University of Luebeck

PhaseNA
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial fibrillation can reduce atrial fibrillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.

This description comes directly from the study's public registry record.

Talk to the study team

Roland Tilz, Prof. Dr.  ·  +49451500  ·  roland.tilz@uksh.de

Charlotte Eitel, Prof. Dr.  ·  +49451500  ·  charlotte.eitel@uksh.de

Always discuss trial participation with your own doctor first.

Locations (3)

University Hospital Eppendorf, Hamburg, GermanyHamburg, Free and Hanseatic City of Hamburg, GermanyRecruiting
Asklepios Klinik AltonaHamburg, Free and Hanseatic City of Hamburg, GermanyRecruiting
Clinic for Rhythmologiy Luebeck, Schleswig-Holstein GermanyLübeck, Schleswig-Holstein, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04240366